Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-09-29
DOI
10.3389/fneur.2015.00207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-Related Imaging Abnormalities in AβPP Duplication Carriers
- (2018) Ludivine Chamard et al. JOURNAL OF ALZHEIMERS DISEASE
- The Inflammatory Form of Cerebral Amyloid Angiopathy or “Cerebral Amyloid Angiopathy-Related Inflammation” (CAARI)
- (2015) Howard S. Kirshner et al. Current Neurology and Neuroscience Reports
- Cerebral Amyloid Angiopathy Associated with Inflammation: Report of 3 Cases and Systematic Review
- (2015) Ana Castro Caldas et al. Journal of Stroke & Cerebrovascular Diseases
- Stroke-Like Episodes Heralding a Reversible Encephalopathy: Microbleeds as the Key to the Diagnosis of Cerebral Amyloid Angiopathy–Related Inflammation—A Case Report and Literature Review
- (2015) Marcelo D. Mendonça et al. Journal of Stroke & Cerebrovascular Diseases
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Cerebral Amyloid Angiopathy Associated with Inflammation: Report of 3 Cases and Systematic Review
- (2015) Ana Castro Caldas et al. Journal of Stroke & Cerebrovascular Diseases
- Stroke-Like Episodes Heralding a Reversible Encephalopathy: Microbleeds as the Key to the Diagnosis of Cerebral Amyloid Angiopathy–Related Inflammation—A Case Report and Literature Review
- (2015) Marcelo D. Mendonça et al. Journal of Stroke & Cerebrovascular Diseases
- Cerebral Amyloid Angiopathy: Emerging Concepts
- (2015) Masahito Yamada Journal of Stroke
- ANTI-Aβ AUTOANTIBODIES IN CAA AND AD: DIFFERENT SINGERS FOR THE SAME ARIA?
- (2014) Fabrizio Piazza et al. Alzheimers & Dementia
- 11C-PiB PET Imaging of Encephalopathy Associated with Cerebral Amyloid Angiopathy
- (2014) Renpei Sengoku et al. INTERNAL MEDICINE
- Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
- (2014) Alberto Lleó et al. Nature Reviews Neurology
- Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult
- (2014) M. R. Raman et al. NEUROLOGY
- Mystery Case: Cerebral amyloid angiopathy-related inflammation
- (2014) A. L. Berkowitz et al. NEUROLOGY
- Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome
- (2014) Matia Martucci et al. NEURORADIOLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- MR Imaging Features of Amyloid-Related Imaging Abnormalities
- (2013) J. Barakos et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: Variations on the Same ARIA?
- (2013) David J. Werring et al. ANNALS OF NEUROLOGY
- Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies
- (2013) Fabrizio Piazza et al. ANNALS OF NEUROLOGY
- Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation
- (2013) Akio Kimura et al. Journal of Neuroinflammation
- Immune Activation in Amyloid-�-Related Angiitis Correlates with Decreased Parenchymal Amyloid-� Plaque Load
- (2013) S. Bogner et al. Neurodegenerative Diseases
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- ARIA from off-key operas?
- (2012) Giovanni B Frisoni LANCET NEUROLOGY
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab
- (2011) Christopher Carlson et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Anti-A autoantibodies in the CSF of a patient with CAA-related inflammation: A case report
- (2011) J. C. DiFrancesco et al. NEUROLOGY
- Life imitates art: Anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy
- (2011) S. M. Greenberg et al. NEUROLOGY
- Brain-reactive -amyloid antibodies in primary cns angiitis with cerebral amyloid angiopathy
- (2011) D. M. Hermann et al. NEUROLOGY
- Increased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients
- (2010) Elisa Conti et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients
- (2010) Elisa Conti et al. NEUROSCIENCE LETTERS
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started